TY - JOUR
T1 - Development and rationale for a multifactorial, randomized controlled trial to test strategies to promote adherence to complex drug regimens among older adults
AU - Bailey, Stacy Cooper
AU - Wismer, Guisselle A.
AU - Parker, Ruth M.
AU - Walton, Surrey M.
AU - Wood, Alastair J.J.
AU - Wallia, Amisha
AU - Brokenshire, Samantha A.
AU - Infanzon, Alexandra C.
AU - Curtis, Laura M.
AU - Kwasny, Mary J.
AU - Wolf, Michael S.
N1 - Funding Information:
Stacy Bailey has served as a consultant to Merck, Sharp & Dohme Corp and Luto LLC for work unrelated to this manuscript. She has also received grant support via her institution from Merck, Sharp & Dohme Corp and Eli Lilly and Company. Michael Wolf has served as a consultant to Merck, Sharp & Dohme Corp, Abbvie, Vivus, Inc., Luto LLC, Anheuser Busch Imbev, DenverHealth, and Teva Pharmaceuticals for work unrelated to this manuscript. He also has received grant support via his institution from Merck, Sharp & Dohme Corp, Eli Lilly and Company, Abbvie, and UnitedHealthcare. Ruth Parker has received grant support from Merck, Sharp & Dohme. Surrey Walton has served as a consultant to Merck, Sharp & Dohme, Abbott and Abbvie, and Baxter for work unrelated to this manuscript. Amisha Wallia has received grant support via her institution from Merck, Sharp & Dohme Corp and Eli Lilly and company. Dr. Wallia also serves as an adjudicator for Lexicon Therapeutics and a consultant for GLytec. Alastair J.J. Wood has served as a consultant to various drug companies and is a partner at Symphony Capital LLC. None of his consulting or work at Symphony Capital was related to the content or topic of this manuscript. Other study authors have no conflicts of interest to disclose.
Funding Information:
This study was funded through NIA 1R01AG046352 . REDCap is supported at the Feinberg School of Medicine by the Northwestern University Clinical and Translational Science (NUCATS) Institute. Research reported in this publication was supported in part by the National Institutes of Health's National Center for Advancing Translational Sciences, Grant Number UL1TR001422 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2017
PY - 2017/11
Y1 - 2017/11
N2 - Background Patients with chronic conditions are often responsible for self-managing complex, multi-drug regimens with minimal professional clinical support. While numerous interventions to promote and support medication adherence have been tested, most have had limited success or have been too resource-intensive for real-world implementation. Objective To compare the effectiveness of multiple low-cost, technology-enabled strategies, alone and in combination, for promoting medication regimen adherence among older adults. Methods Older, English or Spanish-speaking patients on complex drug regimens (N = 1505) will be recruited from a community health system in Chicago, IL. Enrolled patients will be randomized to one of four study arms, receiving either: 1) enhanced usual care alone; 2) daily medication reminders via SMS text messages; 3) medication monitoring via a patient portal-based assessment; or 4) both SMS text message reminders and portal-based medication monitoring. The primary outcome of the study is medication adherence, which will be assessed via multiple measures at baseline, 2 months, and 6 months. The effect of intervention strategies on clinical markers (hemoglobin A1c, blood pressure, cholesterol level), as well as intervention fidelity and the barriers and costs of implementation will also be evaluated. Conclusions This randomized controlled trial will evaluate the impact of various low-cost intervention strategies on adherence to complex medication regimens and will explore barriers to implementation. If the studied intervention strategies are shown to be effective, then these approaches could be effectively deployed across a diverse range of clinical settings and patient populations. Clinical Trial Registration: This trial is registered on clinicaltrials.govNCT02820753.
AB - Background Patients with chronic conditions are often responsible for self-managing complex, multi-drug regimens with minimal professional clinical support. While numerous interventions to promote and support medication adherence have been tested, most have had limited success or have been too resource-intensive for real-world implementation. Objective To compare the effectiveness of multiple low-cost, technology-enabled strategies, alone and in combination, for promoting medication regimen adherence among older adults. Methods Older, English or Spanish-speaking patients on complex drug regimens (N = 1505) will be recruited from a community health system in Chicago, IL. Enrolled patients will be randomized to one of four study arms, receiving either: 1) enhanced usual care alone; 2) daily medication reminders via SMS text messages; 3) medication monitoring via a patient portal-based assessment; or 4) both SMS text message reminders and portal-based medication monitoring. The primary outcome of the study is medication adherence, which will be assessed via multiple measures at baseline, 2 months, and 6 months. The effect of intervention strategies on clinical markers (hemoglobin A1c, blood pressure, cholesterol level), as well as intervention fidelity and the barriers and costs of implementation will also be evaluated. Conclusions This randomized controlled trial will evaluate the impact of various low-cost intervention strategies on adherence to complex medication regimens and will explore barriers to implementation. If the studied intervention strategies are shown to be effective, then these approaches could be effectively deployed across a diverse range of clinical settings and patient populations. Clinical Trial Registration: This trial is registered on clinicaltrials.govNCT02820753.
KW - Chronic conditions
KW - Health literacy
KW - Medication adherence
UR - http://www.scopus.com/inward/record.url?scp=85027875540&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85027875540&partnerID=8YFLogxK
U2 - 10.1016/j.cct.2017.08.013
DO - 10.1016/j.cct.2017.08.013
M3 - Article
C2 - 28823927
AN - SCOPUS:85027875540
SN - 1551-7144
VL - 62
SP - 21
EP - 26
JO - Contemporary Clinical Trials
JF - Contemporary Clinical Trials
ER -